Matinas BioPharma Holdings, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2013 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Matinas BioPharma Holdings, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2013 to Q3 2024.
  • Matinas BioPharma Holdings, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$4.28M, a 29.4% increase year-over-year.
  • Matinas BioPharma Holdings, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$21.1M, a 0.61% increase year-over-year.
  • Matinas BioPharma Holdings, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$22.9M, a 9.26% decline from 2022.
  • Matinas BioPharma Holdings, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$21M, a 9.82% increase from 2021.
  • Matinas BioPharma Holdings, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$23.3M, a 3.73% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$21.1M -$4.28M +$1.78M +29.4% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 -$22.9M -$5.72M +$341K +5.63% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 -$23.3M -$5.82M -$311K -5.64% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$22.9M -$5.31M -$1.68M -46.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-27
Q3 2023 -$21.3M -$6.06M -$593K -10.9% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 -$20.7M -$6.06M -$137K -2.31% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 -$20.5M -$5.51M +$465K +7.78% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$21M -$3.63M +$3.07M +45.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-27
Q3 2022 -$24.1M -$5.46M +$1.37M +20.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 -$25.4M -$5.92M -$1.13M -23.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 -$24.3M -$5.98M -$1.02M -20.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 -$23.3M -$6.7M -$358K -5.65% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-15
Q3 2021 -$22.9M -$6.84M -$1.39M -25.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-02
Q2 2021 -$21.5M -$4.79M +$819K +14.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$22.4M -$4.96M +$89.6K +1.78% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$22.4M -$6.34M -$768K -13.8% Oct 1, 2020 Dec 31, 2020 10-K/A 2022-03-11
Q3 2020 -$21.7M -$5.45M -$1.05M -23.7% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 -$20.6M -$5.61M -$2.27M -67.7% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q1 2020 -$18.4M -$5.05M -$995K -24.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 -$17.4M -$5.57M -$1.95M -53.7% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-29
Q3 2019 -$15.4M -$4.4M -$1.47M -50% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 -$14M -$3.34M +$66.3K +1.94% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$14M -$4.05M +$59.3K +1.44% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 -$14.1M -$3.63M +$1.56K +0.04% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-09
Q3 2018 -$14.1M -$2.94M +$459K +13.5% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 -$14.5M -$3.41M +$557K +14% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-13
Q1 2018 -$15.1M -$4.11M +$386K +8.59% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-13
Q4 2017 -$15.5M -$3.63M -$1.74M -91.8% Oct 1, 2017 Dec 31, 2017 10-K 2019-04-01
Q3 2017 -$13.8M -$3.39M -$1.56M -84.7% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 -$12.2M -$3.97M -$2.34M -144% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 -$9.85M -$4.5M -$2.25M -100% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 -$7.6M -$1.89M +$114K +5.7% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-16
Q3 2016 -$7.71M -$1.84M +$316K +14.7% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 -$8.03M -$1.62M +$781K +32.5% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q1 2016 -$8.81M -$2.24M +$326K +12.7% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 -$9.14M -$2.01M +$1.04M +34.1% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-16
Q3 2015 -$10.2M -$2.15M +$457K +17.5% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 -$10.6M -$2.4M +$21.3K +0.88% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-15
Q1 2015 -$10.7M -$2.57M -$431K -20.2% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-13
Q4 2014 -$10.2M -$3.04M -$1.24M -69% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-31
Q3 2014 -$8.98M -$2.61M -$1.16M -79.3% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-10
Q2 2014 -$7.82M -$2.43M -$2.08M -607% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
Q1 2014 -$5.74M -$2.14M -$2.03M -1808% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-15
Q4 2013 -$3.71M -$1.8M Oct 1, 2013 Dec 31, 2013 10-Q 2015-05-15
Q3 2013 -$1.46M Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-14
Q2 2013 -$343K Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-08
Q1 2013 -$112K Jan 1, 2013 Mar 31, 2013 10-Q/A 2014-06-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.